BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25167783)

  • 1. Improved quality of life in hyperthyroidism patients after surgery.
    Bukvic B; Zivaljevic V; Sipetic S; Diklic A; Tausanovic K; Stojanovic D; Stevanovic D; Paunovic I
    J Surg Res; 2015 Feb; 193(2):724-30. PubMed ID: 25167783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study.
    Cramon P; Winther KH; Watt T; Bonnema SJ; Bjorner JB; Ekholm O; Groenvold M; Hegedüs L; Feldt-Rasmussen U; Rasmussen ÅK
    Thyroid; 2016 Aug; 26(8):1010-8. PubMed ID: 27370744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
    Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
    Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
    Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
    Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C
    Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic nodular goiter and cancer: a compelling case for thyroidectomy.
    Smith JJ; Chen X; Schneider DF; Nookala R; Broome JT; Sippel RS; Chen H; Solorzano CC
    Ann Surg Oncol; 2013 Apr; 20(4):1336-40. PubMed ID: 23108556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graves' disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study.
    Brandt F; Thvilum M; Almind D; Christensen K; Green A; Hegedüs L; Brix TH
    Thyroid; 2013 Apr; 23(4):408-13. PubMed ID: 23253072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthyroid patients without Graves' orbitopathy are not at increased risk of developing glaucoma: a nationwide Danish register-based case-control study.
    Brandt F; Thvilum M; Hegedüs L; Brix TH
    Endocrine; 2018 Jan; 59(1):137-142. PubMed ID: 29198022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects.
    Watt T; Cramon P; Hegedüs L; Bjorner JB; Bonnema SJ; Rasmussen ÅK; Feldt-Rasmussen U; Groenvold M
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3708-17. PubMed ID: 25004246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased birth weight, length, and head circumference in children born by women years after treatment for hyperthyroidism.
    Ohrling H; Törring O; Yin L; Iliadou AN; Tullgren O; Abraham-Nordling M; Wallin G; Hall P; Lönn S
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3217-23. PubMed ID: 24878049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of stressful life events on the initiation of graves' disease.
    Topcu CB; Celik O; Tasan E
    Int J Psychiatry Clin Pract; 2012 Oct; 16(4):307-11. PubMed ID: 22136213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the number and impact of stressful life events and the onset of Graves' disease and toxic nodular goitre.
    Matos-Santos A; Nobre EL; Costa JG; Nogueira PJ; Macedo A; Galvão-Teles A; de Castro JJ
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):15-9. PubMed ID: 11453947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum interleukin-1 beta during treatment of hyperthyroidism with antithyroid drugs.
    Tsatsoulis A; Vlachoyiannopoulos PG; Dalekos GN; Johnson EO; Moutsopoulos HM
    Eur J Clin Invest; 1995 Sep; 25(9):654-8. PubMed ID: 7498238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COMPARISON OF CARDIAC ARRHYTHMIA TYPES BETWEEN HYPERTHYROID PATIENTS WITH GRAVES' DISEASE AND TOXIC NODULAR GOITER.
    Turan E; Can I; Turan Y; Uyar M; Cakır M
    Acta Endocrinol (Buchar); 2018; 14(3):324-329. PubMed ID: 31149279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of radioiodine treatment of hyperthyroidism: a follow-up study.
    Berg G; Michanek A; Holmberg E; Nyström E
    J Intern Med; 1996 Feb; 239(2):165-71. PubMed ID: 8568485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter].
    Pascual Corrales E; Príncipe RM; Laguna Muro S; Martínez Regueira F; Alcalde Navarrete JM; Guillén Grima F; Galofré JC
    Endocrinol Nutr; 2012 Mar; 59(3):169-73. PubMed ID: 22325789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Definitive Surgery for Graves' Disease on Adolescent Disease-Specific Quality of Life and Psychosocial Functioning.
    Halada S; Baran JA; Isaza A; Patel T; Sisko L; Kazahaya K; Adzick NS; Katowitz WR; Magee L; Bauer AJ
    Thyroid; 2022 Dec; 32(12):1519-1528. PubMed ID: 36254382
    [No Abstract]   [Full Text] [Related]  

  • 20. E-selectin, L-selectin, ICAM-1 and IL-6 concentrations changes in the serum of patients with hyperthyroidism in the early period of radioiodine I-131 therapy.
    Jurgilewicz DH; Rogowski F; Łebkowska U; Citko A; Jaroszewicz E; Parfieńczyk A
    Nucl Med Rev Cent East Eur; 2002; 5(1):39-42. PubMed ID: 14600946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.